Similar articles for PMID: 31130438

Year	Number of Results
1989	1
1990	2
1991	4
1992	7
1993	2
1994	6
1995	8
1996	5
1997	4
1998	4
1999	2
2000	2
2001	2
2002	3
2004	1
2005	2
2006	1
2008	1
2009	1
2011	7
2012	1
2014	1
2015	3
2016	9
2017	6
2018	7
2019	4
2020	2
2021	1
2024	0

1

Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response.

Pol S, Fontaine H, Carrat F; on the behalf of the ANRS/AFEF Hepather Study group. Pol S, et al. J Hepatol. 2019 Aug;71(2):446. doi: 10.1016/j.jhep.2019.02.025. Epub 2019 May 23. J Hepatol. 2019. PMID: 31130438 No abstract available.

2

Reply to: "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response".

Sapena V, Rios J, Torres F, Mariño Z, Forns X, Bruix J, Reig M. Sapena V, et al. J Hepatol. 2019 Aug;71(2):447-448. doi: 10.1016/j.jhep.2019.04.018. Epub 2019 Jun 7. J Hepatol. 2019. PMID: 31182374 No abstract available.

3

Letter: the role of direct-acting anti-virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus-induced cirrhosis.

Kao WY, Su CW. Kao WY, et al. Aliment Pharmacol Ther. 2018 Apr;47(8):1230-1231. doi: 10.1111/apt.14565. Aliment Pharmacol Ther. 2018. PMID: 29574869 No abstract available.

4

Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis.

Naoumov NV, Chokshi S, Metivier E, Maertens G, Johnson PJ, Williams R. Naoumov NV, et al. J Hepatol. 1997 Aug;27(2):331-6. doi: 10.1016/s0168-8278(97)80179-1. J Hepatol. 1997. PMID: 9288608

5

Hepatitis C virus infection in cirrhosis and primary hepatocellular carcinoma in Senegal.

Coursaget P, Leboulleux D, Le Cann P, Bao O, Coll-Seck AM. Coursaget P, et al. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):552-3. doi: 10.1016/0035-9203(92)90107-n. Trans R Soc Trop Med Hyg. 1992. PMID: 1282278 No abstract available.

6

The role of hepatitis C virus in liver disease.

Schiff E. Schiff E. J Gastroenterol Hepatol. 1991;6 Suppl 1:29-30. doi: 10.1111/j.1440-1746.1991.tb01164.x. J Gastroenterol Hepatol. 1991. PMID: 1661192 Review. No abstract available.

7

Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.

Ponzetto A, Figura N. Ponzetto A, et al. Gastroenterology. 2018 Apr;154(5):1549. doi: 10.1053/j.gastro.2017.12.043. Epub 2018 Mar 8. Gastroenterology. 2018. PMID: 29526731 No abstract available.

8

Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.

Fattovich G, Llovet JM. Fattovich G, et al. J Hepatol. 2006 Jun;44(6):1013-6. doi: 10.1016/j.jhep.2006.04.001. J Hepatol. 2006. PMID: 16678654 No abstract available.

9

HCV-associated hepatocellular carcinoma without cirrhosis.

el-Refaie A, Savage K, Bhattacharya S, Khakoo S, Harrison TJ, el-Batanony M, Soliman el-S, Nasr S, Mokhtar N, Amer K, Scheuer PJ, Dhillon AP. el-Refaie A, et al. J Hepatol. 1996 Mar;24(3):277-85. doi: 10.1016/s0168-8278(96)80005-5. J Hepatol. 1996. PMID: 8778193

10

External validation of the nomogram for individualized prediction of hepatocellular carcinoma occurrence in patients with hepatitis C virus-related compensated cirrhosis.

Marot A, Vandenbulcke H, Knebel JF, Doerig C, Moreno C, Deltenre P. Marot A, et al. Hepatology. 2017 Apr;65(4):1419-1421. doi: 10.1002/hep.28865. Epub 2016 Nov 29. Hepatology. 2017. PMID: 27737519 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year